Iron Metabolism Disorders - 22 Studies Found
| Completed |
: Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers : Iron Metabolism Disorders : 2008-05-27 :
|
| Completed |
: Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals :
|
| Completed |
: Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) :
: Drug: Iron Isomaltoside The trial is a dose escalating trial. |
| Completed |
: Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation : Chronic Iron Overload : 2016-03-21 : Drug: Deferasirox Deferasirox FCT will be provided as 90 mg, 180 mg and 360 mg film-coated tablets for o |
| Completed |
: Non-invasive Quantification of Liver Iron With MRI :
: 2011-08-17 : Device: Non-contrast MRI Non-contrast MRI will be performed on each subject, at both 1.5T and 3.0T. Diff |
| Completed |
: Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy : Iron Overload : 2013-05-26 |
| Completed |
: Active Drug Surveillance Program of Ferriprox Use : Transfusional Iron Overload : 2013-04-15 |
| Terminated |
: Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184) : Iron Overload Due to Repeated Red Blood Cell Transfusions : 2012-08-16 : Drug: SSP-004184AQ Long term extension study of 8-75 mg/kg/d of SSP-004184AQ (equivalent to 7-68 mg/kg/d |
| Terminated |
: Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy : Iron Overload Due to Repeated Red Blood Cell Transfusions : 2012-05-22 : Drug: SPD602 50 mg/kg/day orally twice daily for 24 weeks |
| Completed |
: Massive Iron Deposit Assessment :
: 2012-04-03 :
|